January 2025
Intermediate to advanced
592 pages
20h 25m
English
book
Blockchain-Enabled Solutions for the Pharmaceutical Industry
by Ritika Wason, Parul Arora, Parma Nand, Vishal Jain, Vinay Kukreja
Content preview from Blockchain-Enabled Solutions for the Pharmaceutical Industry
Become an O’Reilly member and get unlimited access to this title plus top books and audiobooks from O’Reilly and nearly 200 top publishers, thousands of courses curated by job role, 150+ live events each month,
O’Reilly covers everything we've got, with content to help us build a world-class technology community, upgrade the capabilities and competencies of our teams, and improve overall team performance as well as their engagement.I wanted to learn C and C++, but it didn't click for me until I picked up an O'Reilly book. When I went on the O’Reilly platform, I was astonished to find all the books there, plus live events and sandboxes so you could play around with the technology.I’ve been on the O’Reilly platform for more than eight years. I use a couple of learning platforms, but I'm on O'Reilly more than anybody else. When you're there, you start learning. I'm never disappointed.I'm always learning. So when I got on to O'Reilly, I was like a kid in a candy store. There are playlists. There are answers. There's on-demand training. It's worth its weight in gold, in terms of what it allows me to do.
6Pharma-RBT: Blockchain-Enabled Solution for PII-Protected Drug Trails in the Pharmaceutical Industry
Sai Shibu N. B.1*, Rohit Mathew Samuel2, Neeraj Chowdary Vipparla1,3 and Nidhin Mahesh A.4
1Meta Jupiter Software Solutions Private Limited, Hyderabad, India
2Center for Wireless Networks & Applications (WNA), Amrita Vishwa Vidyapeetham, Amritapuri, India
3School of Computing, Amrita Vishwa Vidyapeetham, Amritapuri, India
4Rubix Networks, Hyderabad, India
Abstract
Transparency, data integrity, and patient privacy are prerequisites in clinical drug research. Blockchain has emerged as a novel approach to tackle these significant concerns. This chapter uses blockchain-based decentralised identity (DIDs) to enable anonymous user trials whilst mitigating the potential disclosure of personally identifiable information (PII). Blockchain offers a secure and immutable record that guarantees data integrity, making it suitable for addressing data security and patient confidentiality concerns. However, the challenge is in upholding the anonymity of trial participants whilst simultaneously ensuring the verifiability and reliability of the trial data. DIDs, an essential element of blockchain, provide a unique and innovative solution to this problem. DIDs assign distinct and anonymous identifiers to participants in clinical trials without revealing their PII. Blockchain guarantees the anonymity of data whilst allowing authorised parties to verify it. Trial participants can have full control ...
Become an O’Reilly member and get unlimited access to this title plus top books and audiobooks from O’Reilly and nearly 200 top publishers, thousands of courses curated by job role, 150+ live events each month,
and much more.
Read now
Unlock full access
More than 5,000 organizations count on O’Reilly
O’Reilly covers everything we've got, with content to help us build a world-class technology community, upgrade the capabilities and competencies of our teams, and improve overall team performance as well as their engagement.Julian F.
I wanted to learn C and C++, but it didn't click for me until I picked up an O'Reilly book. When I went on the O’Reilly platform, I was astonished to find all the books there, plus live events and sandboxes so you could play around with the technology.Addison B.
I’ve been on the O’Reilly platform for more than eight years. I use a couple of learning platforms, but I'm on O'Reilly more than anybody else. When you're there, you start learning. I'm never disappointed.Amir M.
I'm always learning. So when I got on to O'Reilly, I was like a kid in a candy store. There are playlists. There are answers. There's on-demand training. It's worth its weight in gold, in terms of what it allows me to do.